Which Margin Should Be Added to the GTV?

  • K. Haustermans
  • I. Joye


During the past decennium, precision of radiotherapy treatment has increased with the implementation of highly-conformal radiotherapy techniques. The steep dose gradients of intensity-modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT) demand precisely defined target volumes and margins.


  1. 1.
    ICRU (1993) Prescribing, recording, and reporting photon beam therapy. ICRU Report 50, International Commission on Radiation Units and Measurements. ICRU, BethesdaGoogle Scholar
  2. 2.
    Appelt AL, Ploen J, Vogelius IR, Bentzen SM, Jakobsen A (2013) Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 85(1):74–80CrossRefPubMedGoogle Scholar
  3. 3.
    Lezoche F, Baldarelli M, Guerrieri M et al (2008) A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22(2):352–358CrossRefPubMedGoogle Scholar
  4. 4.
    Habr-Gama A, Perez RO, Nadalin W et al (2004) Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann Surg 240(4):711–717PubMedPubMedCentralGoogle Scholar
  5. 5.
    Beets-Tan RG, Beets GL, Vliegen RF et al (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet 357(9255):497–504CrossRefPubMedGoogle Scholar
  6. 6.
    Tan J, Lim Joon D, Fitt G et al (2010) The utility of multimodality imaging with CT and MRI in defining rectal tumour volumes for radiotherapy treatment planning: a pilot study. J Med Imaging Radiat Oncol 54(6):562–568CrossRefPubMedGoogle Scholar
  7. 7.
    O’Neill BD, Salerno G, Thomas K, Tait DM, Brown G (2009) MR vs CT imaging: low rectal cancer tumour delineation for three-dimensional conformal radiotherapy. Br J Radiol 82(978):509–513CrossRefPubMedGoogle Scholar
  8. 8.
    Buijsen J, van den Bogaard J, Janssen MH et al (2011) FDG-PET provides the best correlation with the tumor specimen compared to MRI and CT in rectal cancer. Radiother Oncol 98(2):270–276CrossRefPubMedGoogle Scholar
  9. 9.
    Braendengen M, Hansson K, Radu C, Siegbahn A, Jacobsson H, Glimelius B (2011) Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study. Int J Radiat Oncol Biol Phys 81(4):e439–e445CrossRefPubMedGoogle Scholar
  10. 10.
    Roels S, Slagmolen P, Nuyts J et al (2008) Biological image-guided radiotherapy in rectal cancer: is there a role for FMISO or FLT, next to FDG? Acta Oncol 47(7):1237–1248CrossRefPubMedGoogle Scholar
  11. 11.
    Roels S, Slagmolen P, Nuyts J et al (2009) Biological image-guided radiotherapy in rectal cancer: challenges and pitfalls. Int J Radiat Oncol Biol Phys 75(3):782–790CrossRefPubMedGoogle Scholar
  12. 12.
    Krengli M, Cannillo B, Turri L et al (2010) Target volume delineation for preoperative radiotherapy of rectal cancer: inter-observer variability and potential impact of FDG-PET/CT imaging. Technol Cancer Res Treat 9(4):393–398CrossRefPubMedGoogle Scholar
  13. 13.
    Patel DA, Chang ST, Goodman KA et al (2007) Impact of integrated PET/CT on variability of target volume delineation in rectal cancer. Technol Cancer Res Treat 6(1):31–36CrossRefPubMedGoogle Scholar
  14. 14.
    Buijsen J, van den Bogaard J, van der Weide H et al (2012) FDG-PET-CT reduces the interobserver variability in rectal tumour delineation. Radiother Oncol 102(3):371–376CrossRefPubMedGoogle Scholar
  15. 15.
    Nuyttens JJ, Robertson JM, Yan D, Martinez A (2002) The variability of the clinical target volume for rectal cancer due to internal organ motion during adjuvant treatment. Int J Radiat Oncol Biol Phys 53(2):497–503CrossRefPubMedGoogle Scholar
  16. 16.
    Vorwerk H, Liersch T, Rothe H et al (2009) Gold markers for tumor localization and target volume delineation in radiotherapy for rectal cancer. Strahlenther Onkol 185(2):127–133CrossRefPubMedGoogle Scholar
  17. 17.
    Hollmann B, Nijkamp J, Sonke J, Marijnen C (2012) Positional variation on involved mesorectal lymph nodes during RT of rectal cancer. Radiother Oncol 103(1):S181CrossRefGoogle Scholar
  18. 18.
    Roels S, Duthoy W, Haustermans K et al (2006) Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65(4):1129–1142CrossRefPubMedGoogle Scholar
  19. 19.
    Joye I, Haustermans K (2015) Clinical target volume delineation for rectal cancer radiation therapy: time for updated guidelines? Int J Radiat Oncol Biol Phys 91(4):690–691CrossRefPubMedGoogle Scholar
  20. 20.
    Myerson RJ, Garofalo MC, El Naga I et al (2009) Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas. Int J Radiat Oncol Biol Phys 74(3):824–830CrossRefPubMedGoogle Scholar
  21. 21.
    Belgian Procare Workgroup (2006) Multidisciplinary guidelines for the treatment of rectal cancer., pp 14–15

Copyright information

© Springer-Verlag Berlin Heidelberg 2018

Authors and Affiliations

  1. 1.Department of Radiation OncologyUniversity Hospitals LeuvenLeuvenBelgium

Personalised recommendations